• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LAIR-1 免疫抑制受体的晶体结构和胶原蛋白结合位点:对血小板受体 GPVI 胶原蛋白结合的意外影响。

Crystal structure and collagen-binding site of immune inhibitory receptor LAIR-1: unexpected implications for collagen binding by platelet receptor GPVI.

机构信息

Crystal and Structural Chemistry, Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands.

出版信息

Blood. 2010 Feb 18;115(7):1364-73. doi: 10.1182/blood-2009-10-246322. Epub 2009 Dec 10.

DOI:10.1182/blood-2009-10-246322
PMID:20007810
Abstract

Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1), one of the most widely spread immune receptors, attenuates immune cell activation when bound to specific sites in collagen. The collagen-binding domain of LAIR-1 is homologous to that of glycoprotein VI (GPVI), a collagen receptor crucial for platelet activation. Because LAIR-1 and GPVI also display overlapping collagen-binding specificities, a common structural basis for collagen recognition would appear likely. Therefore, it is crucial to gain insight into the molecular interaction of both receptors with their ligand to prevent unwanted cross-reactions during therapeutic intervention. We determined the crystal structure of LAIR-1 and mapped its collagen-binding site by nuclear magnetic resonance (NMR) titrations and mutagenesis. Our data identify R59, E61, and W109 as key residues for collagen interaction. These residues are strictly conserved in LAIR-1 and GPVI alike; however, they are located outside the previously proposed GPVI collagen-binding site. Our data provide evidence for an unanticipated mechanism of collagen recognition common to LAIR-1 and GPVI. This fundamental insight will contribute to the exploration of specific means of intervention in collagen-induced signaling in immunity and hemostasis.

摘要

白细胞相关免疫球蛋白样受体-1(LAIR-1)是分布最广泛的免疫受体之一,当与胶原蛋白中的特定位点结合时,会减弱免疫细胞的激活。LAIR-1 的胶原蛋白结合域与糖蛋白 VI(GPVI)同源,GPVI 是血小板激活的关键胶原蛋白受体。由于 LAIR-1 和 GPVI 也显示出重叠的胶原蛋白结合特异性,因此似乎存在胶原蛋白识别的共同结构基础。因此,深入了解这两个受体与配体的分子相互作用对于防止治疗干预期间发生不必要的交叉反应至关重要。我们通过核磁共振(NMR)滴定和突变分析确定了 LAIR-1 的晶体结构,并绘制了其胶原蛋白结合位点。我们的数据确定 R59、E61 和 W109 是与胶原蛋白相互作用的关键残基。这些残基在 LAIR-1 和 GPVI 中严格保守;然而,它们位于先前提出的 GPVI 胶原蛋白结合位点之外。我们的数据为 LAIR-1 和 GPVI 共有的胶原识别提供了一个出乎意料的机制的证据。这一基本认识将有助于探索在免疫和止血中针对胶原蛋白诱导信号的特异性干预手段。

相似文献

1
Crystal structure and collagen-binding site of immune inhibitory receptor LAIR-1: unexpected implications for collagen binding by platelet receptor GPVI.LAIR-1 免疫抑制受体的晶体结构和胶原蛋白结合位点:对血小板受体 GPVI 胶原蛋白结合的意外影响。
Blood. 2010 Feb 18;115(7):1364-73. doi: 10.1182/blood-2009-10-246322. Epub 2009 Dec 10.
2
Structural insights into collagen binding by platelet receptor glycoprotein VI.血小板受体糖蛋白 VI 与胶原蛋白结合的结构见解。
Blood. 2022 May 19;139(20):3087-3098. doi: 10.1182/blood.2021013614.
3
Platelet collagen receptor Glycoprotein VI-dimer recognizes fibrinogen and fibrin through their D-domains, contributing to platelet adhesion and activation during thrombus formation.血小板胶原受体糖蛋白 VI 二聚体通过其 D 结构域识别纤维蛋白原和纤维蛋白,从而促进血栓形成过程中的血小板黏附和激活。
J Thromb Haemost. 2018 Feb;16(2):389-404. doi: 10.1111/jth.13919. Epub 2018 Jan 15.
4
Identification of the primary collagen-binding surface on human glycoprotein VI by site-directed mutagenesis and by a blocking phage antibody.通过定点诱变和阻断噬菌体抗体鉴定人糖蛋白VI上的主要胶原蛋白结合表面。
Blood. 2004 Feb 1;103(3):903-11. doi: 10.1182/blood-2003-01-0308. Epub 2003 Sep 22.
5
Identification of multiple potent binding sites for human leukocyte associated Ig-like receptor LAIR on collagens II and III.鉴定人白细胞相关免疫球蛋白样受体LAIR在胶原蛋白II和III上的多个强效结合位点。
Matrix Biol. 2009 May;28(4):202-10. doi: 10.1016/j.matbio.2009.03.005. Epub 2009 Apr 2.
6
Efficient inhibition of collagen-induced platelet activation and adhesion by LAIR-2, a soluble Ig-like receptor family member.LAIR-2,一种可溶性免疫球蛋白样受体家族成员,可有效抑制胶原诱导的血小板活化和黏附。
PLoS One. 2010 Aug 13;5(8):e12174. doi: 10.1371/journal.pone.0012174.
7
Identification of residues within human glycoprotein VI involved in the binding to collagen: evidence for the existence of distinct binding sites.鉴定人糖蛋白VI中参与与胶原蛋白结合的残基:存在不同结合位点的证据。
J Biol Chem. 2004 Dec 10;279(50):52293-9. doi: 10.1074/jbc.M406342200. Epub 2004 Oct 4.
8
Structural basis for collagen recognition by the immune receptor OSCAR.免疫受体OSCAR识别胶原蛋白的结构基础。
Blood. 2016 Feb 4;127(5):529-37. doi: 10.1182/blood-2015-08-667055. Epub 2015 Nov 9.
9
Collagen promotes sustained glycoprotein VI signaling in platelets and cell lines.胶原蛋白促进血小板和细胞系中糖蛋白VI的持续信号传导。
J Thromb Haemost. 2007 Nov;5(11):2274-83. doi: 10.1111/j.1538-7836.2007.02746.x. Epub 2007 Aug 22.
10
Gain- and loss-of-function mutants confirm the importance of apical residues to the primary interaction of human glycoprotein VI with collagen.
J Thromb Haemost. 2006 Apr;4(4):869-73. doi: 10.1111/j.1538-7836.2005.01764.x. Epub 2005 Dec 23.

引用本文的文献

1
A Structural Bridge Between Kingdoms: How Collagen-Derived Peptides Influence Plant Stress and Growth Pathways.跨王国的结构桥梁:胶原蛋白衍生肽如何影响植物应激和生长途径。
Physiol Plant. 2025 Sep-Oct;177(5):e70512. doi: 10.1111/ppl.70512.
2
Blocking immune checkpoint LAIR1 with antibody blockade or 3-in-1 CAR T cells enhances antitumor response.用抗体阻断或三功能嵌合抗原受体(CAR)T细胞阻断免疫检查点LAIR1可增强抗肿瘤反应。
J Clin Invest. 2025 Jul 1;135(16). doi: 10.1172/JCI184043.
3
The Role of LAIR1 as a Regulatory Receptor of Antitumor Immune Cell Responses and Tumor Cell Growth and Expansion.
LAIR1作为抗肿瘤免疫细胞反应以及肿瘤细胞生长与增殖的调节性受体的作用。
Biomolecules. 2025 Jun 13;15(6):866. doi: 10.3390/biom15060866.
4
RIFINs displayed on malaria-infected erythrocytes bind KIR2DL1 and KIR2DS1.疟原虫感染的红细胞表面展示的裂殖子表面蛋白(RIFINs)可结合杀伤细胞免疫球蛋白样受体2DL1(KIR2DL1)和杀伤细胞免疫球蛋白样受体2DS1(KIR2DS1)。
Nature. 2025 Jun 11. doi: 10.1038/s41586-025-09091-y.
5
Inhibitory pattern recognition receptors: lessons from LAIR1.抑制性模式识别受体:来自LAIR1的经验教训。
Nat Rev Immunol. 2025 May 27. doi: 10.1038/s41577-025-01181-2.
6
Deciphering the folding code of collagens.破解胶原蛋白的折叠密码。
Nat Commun. 2025 Mar 19;16(1):2702. doi: 10.1038/s41467-024-54046-y.
7
Investigation of Genomic and Transcriptomic Risk Factors of Clopidogrel Response in African Americans.非裔美国人中氯吡格雷反应的基因组和转录组风险因素研究。
Clin Pharmacol Ther. 2025 May;117(5):1313-1324. doi: 10.1002/cpt.3552. Epub 2025 Jan 27.
8
Investigation of genomic and transcriptomic risk factors in clopidogrel response in African Americans.非裔美国人氯吡格雷反应中基因组和转录组风险因素的研究。
medRxiv. 2023 Dec 7:2023.12.05.23299140. doi: 10.1101/2023.12.05.23299140.
9
Luteolin inhibits GPVI-mediated platelet activation, oxidative stress, and thrombosis.木犀草素可抑制糖蛋白VI介导的血小板活化、氧化应激和血栓形成。
Front Pharmacol. 2023 Oct 31;14:1255069. doi: 10.3389/fphar.2023.1255069. eCollection 2023.
10
Material matters: exploring the interplay between natural biomaterials and host immune system.物质 Matters:探索天然生物材料与宿主免疫系统的相互作用。
Front Immunol. 2023 Oct 23;14:1269960. doi: 10.3389/fimmu.2023.1269960. eCollection 2023.